======= GALR1 ======= == Gene Information == * **Official Symbol**: GALR1 * **Official Name**: galanin receptor 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2587|2587]] * **UniProt**: [[https://www.uniprot.org/uniprot/P47211|P47211]] * **Interactions**: [[https://thebiogrid.org/search.php?search=GALR1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20GALR1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/600377|Open OMIM]] == Function Summary == * **Entrez Summary**: The neuropeptide galanin elicits a range of biological effects by interaction with specific G-protein-coupled receptors. Galanin receptors are seven-transmembrane proteins shown to activate a variety of intracellular second-messenger pathways. GALR1 inhibits adenylyl cyclase via a G protein of the Gi/Go family. GALR1 is widely expressed in the brain and spinal cord, as well as in peripheral sites such as the small intestine and heart. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Receptor for the hormone galanin. The activity of this receptor is mediated by G proteins that inhibit adenylate cyclase activity. {ECO:0000269|PubMed:25691535, ECO:0000269|PubMed:7524088}. |7TM GPCR Srw| |7tm 1| |positive regulation of cortisol secretion| |positive regulation of glucocorticoid secretion| |regulation of cortisol secretion| |positive regulation of corticosteroid hormone secretion| |galanin receptor activity| |positive regulation of steroid hormone secretion| |regulation of glucocorticoid secretion| |regulation of corticosteroid hormone secretion| |negative regulation of adenylate cyclase activity| |regulation of steroid hormone secretion| |negative regulation of cyclase activity| |neuropeptide binding| |negative regulation of lyase activity| |regulation of adenylate cyclase activity| |positive regulation of response to drug| |peptide hormone binding| |G protein-coupled peptide receptor activity| |regulation of cyclase activity| |regulation of endocrine process| |regulation of lyase activity| |positive regulation of lipid transport| |positive regulation of lipid localization| |regulation of response to drug| |neuropeptide signaling pathway| |regulation of lipid transport| |adenylate cyclase-activating G protein-coupled receptor signaling pathway| |positive regulation of hormone secretion| |regulation of lipid localization| |cAMP-mediated signaling| |cyclic-nucleotide-mediated signaling| |adenylate cyclase-modulating G protein-coupled receptor signaling pathway| |G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger| |regulation of hormone secretion| |positive regulation of cytosolic calcium ion concentration| |regulation of cytosolic calcium ion concentration| |second-messenger-mediated signaling| |positive regulation of secretion by cell| |positive regulation of secretion| |cellular calcium ion homeostasis| |calcium ion homeostasis| |cellular divalent inorganic cation homeostasis| |divalent inorganic cation homeostasis| |regulation of hormone levels| |cellular metal ion homeostasis| |regulation of system process| |metal ion homeostasis| |cellular cation homeostasis| |cellular ion homeostasis| |cation homeostasis| |inorganic ion homeostasis| |cellular chemical homeostasis| |regulation of secretion by cell| |ion homeostasis| |negative regulation of catalytic activity| |regulation of secretion| |cellular homeostasis| |positive regulation of transport| |chemical homeostasis| |negative regulation of molecular function| |positive regulation of transcription by RNA polymerase II| |G protein-coupled receptor signaling pathway| |integral component of plasma membrane| |positive regulation of transcription, DNA-templated| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |homeostatic process| |intracellular signal transduction| |positive regulation of RNA metabolic process| |positive regulation of multicellular organismal process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of transport| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp160|Ribavirin 10 to 15μM on day4 R04 exp160]]|-1.87| |[[:results:exp318|ABT-702 5μM R07 exp318]]|-1.7| |[[:results:exp46|HMS-I1 1μM R01 exp46]]|1.77| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 4962 * **Expression level (log2 read counts)**: 2.47 {{:chemogenomics:nalm6 dist.png?nolink |}}